Results of the Phase 2 Trial of Olaparib + Radium-223 vs Radium-223 in Men With CRPC With Bone Metastases (COMRADE) led by the PCCTC’s Dr McKay published in JCO May 15 Written By Kristofer Prepelica, PhD Kristofer Prepelica, PhD
Results of the Phase 2 Trial of Olaparib + Radium-223 vs Radium-223 in Men With CRPC With Bone Metastases (COMRADE) led by the PCCTC’s Dr McKay published in JCO May 15 Written By Kristofer Prepelica, PhD Kristofer Prepelica, PhD
